FutureFuel Corp. Q3 2026 Earnings Recap

FutureFuel fell 38.5% after earnings, with the clearest disappointment coming from weak Chemicals segment throughput: customer turnarounds cut sales volume 27% year over year and reduced adjusted EBITDA by about $4.3 million. Biofuel utilization improved, but elevated feedstock costs and derivative losses still drove a segment gross loss.

Key Takeaways

• Chemicals sales volume declined 27% versus the prior-year quarter amid extended maintenance at dedicated units for two customers; both turnarounds are now complete.
• The Chemicals disruption reduced third-quarter adjusted EBITDA by approximately $4.3 million and hurt operating leverage.
• Biofuel utilization exceeded 80%, its highest level in more than two years, but higher feedstock costs and derivative losses outweighed improved volume and price capture.
• FutureFuel expects to sell $1.5 million of RINs and recover $2.3 million of derivative losses in the fourth quarter.
• Management cited a potential $5 million–$10 million opportunity beginning in 2027 from refining biodiesel glycerin, and expects initial production for a new European chemicals customer in Q1 2027, reaching full rates by midyear.